📊 ENOV Key Takeaways
Is ENOV a Good Investment? Thesis Analysis
Enovis is experiencing severe operational distress with a -50% operating margin and -52.7% net margin, converting a healthy 59.8% gross margin into substantial net losses. While revenue growth of 6.7% YoY and positive operating cash flow of $217.3M suggest underlying business activity, the company is burning through equity rapidly with ROE of -79.5%, indicating fundamental profitability challenges that must be resolved before investment consideration.
Why Buy ENOV? Key Strengths
- Solid gross margin of 59.8% demonstrates strong pricing power and cost-of-goods-sold efficiency in core operations
- Positive operating cash flow of $217.3M indicates the company can still generate cash from business operations despite net losses
- Revenue growth of 6.7% YoY shows market demand and ability to expand top line in orthopedic appliances sector
- Adequate liquidity with 2.02x current ratio and minimal cash burn provides operational runway
ENOV Investment Risks to Consider
- Massive operating losses of -$1.1B and net losses of -$1.2B indicate severe structural profitability problems requiring immediate operational restructuring
- Negative ROE of -79.5% and ROA of -30.9% demonstrate extremely poor capital efficiency and value destruction for shareholders
- Operating margin of -50% is unsustainable; company is losing $0.50 on every dollar of revenue generated, suggesting unfixable cost structure or massive one-time charges
- Free cash flow of only $19.9M (0.9% FCF margin) after capex represents dangerous margin for error; minimal buffer for debt service
- Long-term debt of $1.3B with negative interest coverage ratio of -32.3x creates refinancing risk and financial instability
- Deteriorating EPS of -$20.75 per share with -39% YoY decline indicates shareholder value destruction is accelerating
Key Metrics to Watch
- Operating margin recovery timeline - critical to confirm losses are temporary or structural
- Operating cash flow sustainability - whether $217.3M can be maintained as net losses continue
- Debt refinancing plans and covenant compliance given negative interest coverage
- Gross margin stability - whether 59.8% level can be maintained amid operational restructuring
- Management commentary on path to profitability and estimated turnaround timeline
ENOV Financial Metrics
💡 AI Analyst Insight
The relatively thin 0.9% FCF margin may limit capital allocation flexibility. Strong liquidity with a 2.02x current ratio provides a solid financial cushion.
ENOV Profitability Ratios
ENOV vs Default Sector
How Enovis CORP compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is ENOV Overvalued or Undervalued?
Based on fundamental analysis, Enovis CORP shows some fundamental concerns relative to the Default sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
ENOV Balance Sheet & Liquidity
ENOV 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: Enovis CORP's revenue has declined by 42% over the 5-year period, indicating business contraction. The most recent EPS of $-0.61 indicates the company is currently unprofitable.
ENOV Growth Metrics (YoY)
ENOV Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $505.2M | -$31.5M | $-0.58 |
| Q2 2025 | $525.2M | -$18.6M | $-0.34 |
| Q1 2025 | $516.3M | -$56.0M | $-0.98 |
| Q3 2024 | $417.5M | -$2.9M | $-0.05 |
| Q2 2024 | $428.5M | -$10.0M | $-0.18 |
| Q1 2024 | $406.2M | -$23.4M | $-0.43 |
| Q3 2023 | $383.8M | -$2.9M | $-0.05 |
| Q2 2023 | $395.1M | -$10.0M | $-0.18 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
ENOV Capital Allocation
ENOV SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for Enovis CORP (CIK: 0001420800)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ENOV
What is the AI rating for ENOV?
Enovis CORP (ENOV) has an AI rating of SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are ENOV's key strengths?
Claude: Solid gross margin of 59.8% demonstrates strong pricing power and cost-of-goods-sold efficiency in core operations. Positive operating cash flow of $217.3M indicates the company can still generate cash from business operations despite net losses.
What are the risks of investing in ENOV?
Claude: Massive operating losses of -$1.1B and net losses of -$1.2B indicate severe structural profitability problems requiring immediate operational restructuring. Negative ROE of -79.5% and ROA of -30.9% demonstrate extremely poor capital efficiency and value destruction for shareholders.
What is ENOV's revenue and growth?
Enovis CORP reported revenue of $2.2B.
Does ENOV pay dividends?
Enovis CORP pays dividends, with $5.1M distributed to shareholders in the trailing twelve months.
Where can I find ENOV SEC filings?
Official SEC filings for Enovis CORP (CIK: 0001420800) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ENOV's EPS?
Enovis CORP has a diluted EPS of $-20.75.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ENOV a good stock to buy right now?
Based on our AI fundamental analysis in March 2026, Enovis CORP has a SELL rating with 85% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is ENOV stock overvalued or undervalued?
Valuation metrics for ENOV: ROE of -79.5% (sector avg: 15%), net margin of -52.7% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy ENOV stock in 2026?
Our dual AI analysis gives Enovis CORP a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ENOV's free cash flow?
Enovis CORP's operating cash flow is $217.3M, with capital expenditures of $197.4M. FCF margin is 0.9%.
How does ENOV compare to other Default stocks?
Vs Default sector averages: Net margin -52.7% (avg: 12%), ROE -79.5% (avg: 15%), current ratio 2.02 (avg: 1.8).